Curcumin targets multiple enzymes involved in the ROS metabolic pathway to suppress tumor cell growth
Abstract Curcumin has been reported to exhibit anti-tumorigenic activity; however, since its precise actions remain unclear, its effects are considered to be deceptive. In the present study, we confirmed the anti-tumorigenic effects of curcumin on CML-derived leukemic cells in a xenograft model and...
Guardado en:
Autores principales: | Yonika Arum Larasati, Noriko Yoneda-Kato, Ikuko Nakamae, Takashi Yokoyama, Edy Meiyanto, Jun-ya Kato |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/07f6f3b6ec8249c3a3d4c9e91b652c41 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
New curcumin analog, CCA-1.1, synergistically improves the antiproliferative effect of doxorubicin against T47D breast cancer cells
por: Febri Wulandari, et al.
Publicado: (2020) -
Illuminating the effect of beneficial blue light and ROS-modulating enzymes in Dupuytren's disease.
por: Carina Jaekel, et al.
Publicado: (2021) -
Suppression of mitochondrial ROS by prohibitin drives glioblastoma progression and therapeutic resistance
por: Haohao Huang, et al.
Publicado: (2021) -
Targeted scavenging of extracellular ROS relieves suppressive immunogenic cell death
por: Hongzhang Deng, et al.
Publicado: (2020) -
Author Correction: Targeted scavenging of extracellular ROS relieves suppressive immunogenic cell death
por: Hongzhang Deng, et al.
Publicado: (2021)